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Abstract
The pathogenesis of human influenza H5N1 virus infection remains poorly understood and controversial. Cytokine
dysregulation in human infection has been hypothesized to contribute to disease severity. We developed in vitro cultures of
mouse bone marrow derived macrophages (BMDMW) from C57BL/6N mouse to compare influenza A (H5N1 and H1N1) virus
replication and pro-inflammatory cytokine and chemokine responses. While both H1N1 and H5N1 viruses infected the
mouse bone marrow derived macrophages, only the H1N1 virus had showed evidence of productive viral replication from
the infected cells. In comparison with human seasonal influenza H1N1 (A/HK/54/98) and mouse adapted influenza H1N1 (A/
WSN/33) viruses, the highly pathogenic influenza H5N1 virus (A/HK/483/97) was a more potent inducer of the chemokine,
CXCL 10 (IP-10), while there was not a clear differential TNF-a protein expression pattern. Although human influenza viruses
rarely cause infection in mice without prior adaption, the use of in vitro cell cultures of primary mouse cells is of interest,
especially given the availability of gene-defective (knock-out) mice for specific genes.
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Introduction
Ferret, rather than mouse is the experimental model of choice
for studying influenza viruses, as many human seasonal influenza
viruses do not infect or cause disease in mice without prior
adaptation. However, because of the extensive availability of
immunological reagents and the fact that mice are with a range of
specific gene defects (knock-out mice); they remain an important
animal model for investigating influenza pathogenesis. Many
highly pathogenic avian influenza (HPAI) viruses including the
current influenza H5N1 viruses do replicate in mice without prior
adaptation. Human H5N1 cases continue to be reported in the
Asian countries including Cambodia, China, Indonesia, Thailand,
and Vietnam and in Egypt [1,2]. All of them have coincided with
outbreaks of highly pathogenic H5N1 avian influenza in poultry.
The overall death rate of H5N1 patient ranges from 33% in Hong
Kong in 1997 up to approximately 60% in recent outbreaks [3].
Although such case fatality estimates may be skewed by case
ascertainment biased to more severely ill patients, it is clear that
HPAI H5N1 disease is associated with unusual virulence for
humans. Despite its inability to transmit efficiently from human to
human, H5N1 virus remains one with significant pandemic
concerns, not only because of its inevitability to start a pandemic
but also to the disease severity of such event [1]. Therefore a better
understanding of its pathogenesis is of high priority.
Human influenza A viruses have been previously reported to
induce keratinocyte-derived chemokine (CXCL1), interleukin 1b
(IL-1b), IL-6 and RANTES (regulated on activation, normal T cell
expressed and secreted) in vivo in the lung of Balb/c mice [13,14].
Our previous studies on human airway epithelial cell [4,5] and
peripheral blood derived macrophages [6] have reported that
H5N1 viruses are more potent in inducing the release of pro-
inflammatory cytokine and chemokine, when compared to H1N1
virus. Large quantities of type I interferon (IFN), tumor necrosis
factor-alpha (TNF-a), IL-1, IL-6 and mononuclear cell attracting
chemokine (CCL3/MIP-1a, CCl4/MIP-1b, CCL5/RANTES,
CXCL10/IP-10) were also detected after influenza A virus
inoculation of human, rat and mouse macrophages cell line [15–
18]. These studies of innate immune responses upon influenza
virus infection in human were performed in different cell types and
suggested that hyper-induction of cytokines plays an crucial role in
the pathogenesis of human H5N1 disease. However, more studies
have found that, human macrophages of different origins, resting
alveolar macrophages and peripheral blood monocyte derived
macrophages [7,8], with different methods of differentiation [9]
would differ in influenza virus permissiveness and host response
profile. Previous in vivo inbred mouse studies [10–12] also shed
some light on the H5N1 pathogenesis, however, the response and
the interaction between individual cell types and H5N1 influenza
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virus were not yet studied. Therefore, it is important to
characterise the mouse macrophages as an experimental model
in terms of permissiveness and host response profile upon the
infection of different influenza virus subtypes.
In this study, we evaluated the permissiveness and pro-
inflammatory cytokine and chemokine responses to influenza
H1N1 and H5N1 viruses in C57bl/6N mouse isolated BMDMW
in vitro. It is shown that both influenza H1N1 and H5N1 viruses
infected these cells, but only the H1N1 viruses had showed
evidence of releasing infectious virus from infected macrophages.
In comparison to human influenza H1N1 (A/HK/54/98) virus or
mouse adapted influenza H1N1 virus (A/WSN/33), influenza
H5N1 (A/HK/483/97) virus was a more potent inducer of the
chemokine CXCL 10 (IP-10) but there was no clear pattern in
regard to expression of TNF-a protein.
Materials and Methods
Viruses
The viruses investigated were an influenza virus isolated from
a patient with fatal influenza H5N1 disease in Hong Kong in
1997, A/Hong Kong/483/97 (483/97) (H5N1 clade 0); a virus
isolated from a patient with fatal H5N1 disease in Vietnam in
2004, A/Vietnam/3046/04 (3046/04) (H5N1 clade 1), a human
seasonal influenza H1N1 virus, A/Hong Kong/54/98 (54/98)
and a mouse adapted influenza H1N1 virus, A/WSN/33 (WSN/
33). Viruses were initially isolated and seed virus stocks were
prepared in Madin-Darby canine kidney (MDCK) cells. Virus
infectivity was titrated to determine tissue culture infection dose
50% (TCID50) in MDCK cells. The influenza H5N1 virus used in
this study was handled in a Bio-safety level 3 (BSL-3) facilities in
the Centre of Influenza Research, School of Public Health, The
University of Hong Kong.
Figure 1. Cell characterization and lectin profile of the mouse bone marrow derived macrophages. Histogram showing the percentage
of positive stained mouse bone marrow derived macrophages by flow cytometry (open peak-blue line). Isotype control (open peak-black line) and
non-stained cells as negative control (shaded peak) of bone marrow derived macrophages stained with (A) CD14 and (B) F4/80. Lectin immune-
staining assay to determine the sialic acid (SA) distribution on mouse bone marrow derived macrophages. (C) Maackia amurensis lectin (MAA)
conjugated with FITC (the lectin that binds SA-a2,3Gal linked sialic acid) and (D) with Sambucus nigra lectin (SNA) conjugated with FITC (the lectin
that binds SA-a2,6GalNAc).
doi:10.1371/journal.pone.0051057.g001
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Mouse Bone Marrow Derived Macrophages (BMDMW)
Female C57bl/6N mice, 6 to 8 weeks old (Laboratory Animal
Unit of The University of Hong Kong) were sacrificed using
cervical dislocation before macrophage extraction under a study
approved by the committee on the Use of Live Animals in
Teaching and Research (CULATR) of the University of Hong
Kong. Cell extraction, isolation and cultivation were performed in
Bio-safety level 2 (BSL-2) cabinets to minimize possible bacterial
contamination of cell cultures. Both edges of the femurs were cut
and a 25-G needle was used to flush out the marrow. The marrow
plug was then dispersed into single cells and was centrifuged at
400 g for 5 min. Gey’s solution in ice was used to lyse the
erythrocytes in the cell suspension for 4 minutes and an equal
volume of RPMI-1640 medium with 5% FCS was added prior to
centrifugation. The cell pellet was then washed with warm RPMI-
1640 at least twice and then resuspended in the RPMI-1640
medium supplemented with 5% FCS, 100 units/mL penicillin and
100 mg/mL streptomycin, 1.3mg/mL Amphotericin B (Cambrex
Bio Science, Walkersville, Inc., Maryland, USA) and 6 ng/mL
recombinant Macrophage Colony Stimulating Factor (M-CSF,
R&D systems). The cells were seeded at a density of 56105 cells/
ml in bacteriologic grade petri-dishes for 14 days to allow
differentiation. After the trypan-blue exclusion test, viable cells
were seeded into tissue culture grade 24-well plates at a density of
26105cells/ml on coverslips. Purity of MW was confirmed by flow
cytometry (FACSSCalibur; Becton Dickinson). A 1:50 dilution of
fluorescein isothiocyanate (FITC) conjugated rat anti-mouse
CD14 and F4/80 antibodies (eBioscience, San Diego, CA, USA,
Figure 2. Representative immunofluorescence staining of mouse bone marrow derived macrophages after (A) Mock; (B) A/WSN/33;
(C) A/HK/54/98 (H1N1); (D) A/HK/483/97 (H5N1) and (E) A/VN/3046/04 (H5N1) influenza A viruses infection. FITC-conjugated mouse
antibodies (DAKO Imagen, Dako Diagnostics Ltd, Ely, UK) reacting with influenza virus matrix and nucleoprotein was used and viewed in an
immunofluoresecent microscope. Mouse bone marrow derived macrophages at 20 hours post-influenza virus infection is shown.
doi:10.1371/journal.pone.0051057.g002
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24uC, 45 min) were used. The FITC-stained cells were detected by
measuring green light emitted at 530 nm (FL1 channel).
Flow Cytometry
BMDMWs was detached from the culture dish using cold
16PBS with 20 mM EDTA. The detached cells were washed once
with PBS and centrifuged at 400 g for 5 minutes. The cells were
then incubated in PBS supplemented with 0.1 g/100 ml bovine
serum albumin solution with 10% FCS for 30 minutes at room
temperature and pelleted by centrifugation at 400 g for 10
minutes. The pellet was then resuspended in 100ml of PBS
supplemented with 0.1 g/100 ml bovine serum albumin solution
with 10% FCS. 10ml of PE-Cy7-labeled anti-mouse-CD14
antibody and PE labeled anti-mouse-F4/80 staining were used
in the case of dual staining (eBioscience, San Diego, CA, USA).
The respective antibody and cells were mixed and incubated for
45 minutes at room temperature. The cells were then washed once
with 16PBS and analyzed using flow cytometer. Cell suspension
without the addition of antibodies and their corresponding isotype-
control antibodies (PE-Cy7 conjugated IgG1 and PE conjugated
IgG1 (eBioscience) were used as negative control.
Lectin Immunofluorescence Assay
BMDMWs monolayer was fixed using 4% paraformaldehyde for
1 hour and washed with PBS. 0.1 M Tris buffer at pH 7.4 with
150 mM NaCl (TBS) was used to wash the cells for three times.
The cells were then incubated with 1:100 FITC conjugated
Sambucus nigra lectin (SNA-I) (EY laboratories, Inc. R-6802-1) and
1:100 FITC conjugated Maackia amurensis lectin (MAA) (EY
laboratories, Inc. F-7801-2) diluted with 0.1 M TBS for 1 hour
at room temperature in dark. After incubation, the cells were
washed using 0.1 M TBS for three times and the nuclei of the cells
were stained using 5 mg/ml DAPI for 4 minutes. The cells were
washed again with 0.1 M TBS for three times and the coverslips
were mounted with DAKO fluorescent mount (Dako, S3023).
Influenza Virus Infection of BMDMW
Mouse BMDMWs in 24-well tissue-culture plate was infected at
a multiplicity of infection (MOI) of two unless otherwise indicated.
After 1 hour of virus adsorption, the virus inoculum was removed
and the cells were washed with warm culture medium. After 20
hours of infection, the cell monolayer was fixed with 4%
paraformaldehyde. Evidence of viral infection was established by
(a) assaying viral matrix RNA after infection by quantitative RT-
PCR, (b) viral antigen expression by immunofluorescence staining
with mouse anti-influenza nucleoprotein and matrix antibody
conjugated with FITC (DAKO Imagen, Dako Diagnostics Ltd,
Ely, UK) and (c) assaying infectious virus in cell culture
supernatant by TCID50 assay to demonstrate complete virus
replication.
Viral titration by TCID50 Assay
A confluent 96-well tissue culture plate of MDCK cells was
prepared one day before the virus titration (TCID50) assay. Cells
were washed once with PBS and replenished with serum-free
MEM medium supplemented with 100 units/ml penicillin and
100 mg/ml streptomycin and 2 mg/ml of supernatant. Serial
dilution was performed (from 0.5 log10 to 7 log10 dilution) and the
virus dilutions were added onto the plates in quadruplicate. The
plates were observed for cytopathic effect daily. The end-point of
viral dilution leading to CPE in 50% of inoculated wells was
estimated using the Karber method [19].
Quantification of Cytokine mRNA by Real-time
Quantitative RT-PCR
DNase-treated total RNA was isolated by means of RNeasy
Mini kit (QIAGEN, Hilden, Germany). The cDNA was synthe-
sized from mRNA with poly(dT) primers and Superscript III
reverse transcriptase (Life Technologies, Rockville, MD, USA) and
Figure 3. Viral matrix (M) gene expression copy number
normalized to b-actin gene expression (105 copies) by quan-
titative RT-PCR in influenza virus infected mouse bone marrow
derived macrophages. Matrix gene mRNA copy number was assayed
3 h, 6 h and 24 h post-infection and normalized to those of b-actin
mRNA in the corresponding sample. Means of triplicate assays are
shown with standard error. Asterisk indicates statistical difference
(p,0.05).
doi:10.1371/journal.pone.0051057.g003
Figure 4. Virus titer detected in the supernatant of influenza A
virus infected mouse bone marrow derived macrophages. Virus
titer of various (A) influenza H1N1, and (B) H5N1 influenza viruses was
determined at 3, 24, 48 and 72 h post-influenza virus infection of mouse
bone marrow derived macrophages. Means and standard error of
triplicate assays were shown. Dotted line represents the lowest
detection limit of the TCID50 assay. The thermal inactivation (serial
dilution of influenza virus was incubated in the cell-free culture medium
alone at the corresponding time points) curves (dotted line) of influenza
H1N1 and H5N1 viruses at 37uC were determined from culture wells
without macrophages.
doi:10.1371/journal.pone.0051057.g004
H5N1 Infection of Mouse Macrophages
PLOS ONE | www.plosone.org 4 November 2012 | Volume 7 | Issue 11 | e51057
quantified by real-time PCR analysis with a LightCycler (Roche,
Mannheim, Germany). The mRNA for tumor necrosis factor
alpha (TNF-a), interferon beta (IFN-b), CXCL-10 (IFN-gamma-
inducible protein-10, IP-10) and CCL5 (Regulated on Activation,
Normal T Expressed and Secreted, RANTES) were quantified
using real-time RT-PCR. The oligonucleotide primers and
methods used for real-time quantification of mouse cytokines,
viral matrix gene and the housekeeping gene product b-actin
mRNA have been described previously by others [20–22] and our
group [4–6,23,24].
Quantification of Cytokine Proteins by ELISA
The concentrations of TNF-a, IP-10 and interferon-beta
proteins in the mouse MWs supernatants were measured by
a specific ELISA assay (R&D Systems, Minneapolis, MN, USA).
Samples of culture supernatant were irradiated with ultraviolet
light (CL-100 Ultra Violet Cross linker) for 15 minutes to
inactivate any infectious virus before the ELISA assays were
done. Previous experiments had confirmed that the dose of
ultraviolet light used did not affect cytokine concentration as
measured by ELISA (data not shown).
Statistical Analysis
Two-tailed student t-test was used to compare the differences
among viral titers in the influenza virus infected cell supernatants
between early and late time points post-infection. The quantitative
cytokine and chemokine mRNA and protein expression profile of
mock, influenza H1N1 and H5N1 virus infected cells were
compared using one-way ANOVA, followed by Bonferroni multi-
ple-comparison test. Differences were considered significant at
p,0.05.
Figure 5. Cytokine and chemokine gene expression in mouse bone marrow derived macrophages after influenza A virus infection.
The cytokines (A) TNF-a, (B) IFN-b, (C) IP-10 (CXCL-10) and (D) RANTES (CCL-5) mRNA gene expression profile of influenza-virus-infected mouse bone
marrow derived macrophages were analyzed by quantitative RT-PCR. The graph shows the mean and the standard error from three independent
experiments. Single and double asterisks indicate statistically significant difference with p,0.05 and p,0.01 respectively.
doi:10.1371/journal.pone.0051057.g005
H5N1 Infection of Mouse Macrophages
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Results
Cell Characterization and Lectin Profile of BMDMW
The yield of the primary culture of mouse bone marrow derived
macrophages were 3.560.96106 cells/mouse at 9365% cell
purity as demonstrated by the expression of the macrophage
specific markers CD14 and F4/80 antibodies by flow cytometry
(Fig. 1A and 1B).
Lectin immunohistochemistry on the primary culture of mouse
bone marrow derived macrophages showed that both lectins,
MAA (Fig. 1C) (which recognizes the accepted avian influenza
receptor Siaa2-3Gal) and SNA (Fig. 1D) (which recognizes the
human influenza receptor Siaa2-6) bound strongly to the mouse
bone marrow derived macrophages.
Influenza Virus Infection of BMDMW
Previous studies have demonstrated that avian influenza viruses
can infect mice intra-nasally in vivo [11] and human peripheral
blood derived macrophages [6] and human airway epithelial cells
in vitro [4,5,23]. We first determined whether avian and human
influenza viruses could infect mouse bone marrow derived
macrophages in vitro. The cells were infected with influenza
H5N1 (483/97 and 3046/04) and H1N1 (WSN/33 and 54/98) at
a MOI of 2, and the proportion of cells expressing influenza A
virus protein was analyzed at 20 h post-infection by immunoflu-
orescence assay using an antibody specific for the virus nucleo-
protein and matrix proteins. Similar proportions (about 95%) of
BMDMW infected with both influenza H5N1 and H1N1 viruses
had evidence of viral antigen (Fig. 2).
There was an increase in influenza matrix gene expression from
3 hours to 24 hours post-infection with all four influenza strains
(Fig. 3). However, productive replication was only observed in
BMDMW infected with influenza H1N1 (54/98 and WSN/33)
subtype (Fig. 4A) but not in influenza H5N1 (483/97 and 3046/
04) subtype (Fig. 4B). WSN/33 replicated effectively and yielded
the highest viral load (Fig. 4A). Thermal inactivation curves of
influenza viruses at 37uC were plotted to show the virus
inactivation kinetics from culture wells without cells. The
difference between the virus load of the infected cultures and the
inactivation curve confirmed the presence of higher (and indeed
increasing) virus titers from infected cell was due to productive
virus replication (Fig. 4).
Induction of Proinflammatory Cytokine and Chemokine
in BMDMW
We investigated the cytokine and chemokine induction profile
induced by influenza H1N1 and H5N1 viruses in primary cultures
of mouse bone marrow derived macrophages. The mRNA
expression of TNF-a, IFN-b, RANTES, IP-10 and the house-
keeping gene, b-actin was quantified using quantitative RT-PCR
at 3, 6 and 24 hours post-infection. The mRNA levels of TNF-
a (Fig. 5A), IFN-b (Fig. 5B), IP-10 (Fig. 5C) and RANTES
(Fig. 5D) after 24 hours post-infection were significantly up-
regulated by influenza H5N1 virus (483/97) when compared with
the mock infected cells (with p,0.01 with TNF-a, p,0.05 with
IFN-b, p,0.001 with IP-10 and p,0.01 with RANTES), H1N1
viruses infected cells (with p,0.05 in TNF-a and p,0.01 with IP-
10), and the mouse adapted WSN/H1N1 virus (with p,0.01 with
TNF-a and IP-10). There was a trend suggesting that the IFN-
b and RANTES gene expressions were more induced by influenza
H5N1 virus (483/97) at 24 hours post-infection when compared to
that in influenza H1N1 (54/98) and mouse adaptive H1N1
(WSN/33) viruses infected mouse macrophages, but statistical
significance was not achieved (Figure 5B and 5D).
Inactivation of the virus by ultraviolet irradiation prior to
infection of the mouse macrophages abolished cytokine induction
(data not shown) suggesting that virus replication was required for
cytokine induction. Furthermore, even an increase in the MOI of
influenza H1N1 (54/98 and WSN/33) viruses up to 10 did not
result in the cytokine and chemokine mRNA expression level to
levels similar to those induced by influenza H5N1 (483/97) virus
(data not shown). The observations remained valid whether the
cytokine mRNA expression data were analyzed with or without
normalization for b-actin mRNA concentrations (data not shown).
Secretion of Cytokine Proteins from BMDMW
We further investigated the secretion of cytokine proteins from
BMDMW infected by influenza H1N1 and H5N1 viruses. The
protein concentrations of the TNF-a, IP-10 and IFN b were
measured by ELISA in culture supernatants of BMDMW infected
by the influenza A viruses. There appeared to have discordance
between TNF-a mRNA expression and the TNF-a protein
secretion in infected BMDMW (Figure 6A). The mouse adapted
influenza H1N1 virus (WSN/33) which is lethal to mice in vivo,
induced larger amount of TNF-a secretion than mock (p = 0.05)
Figure 6. Cytokine and chemokine secretion from mouse bone marrow derived macrophages after influenza A virus infection. (A)
TNF-a (B) IP-10 protein secreted by the mouse bone marrow derived macrophages after influenza A viruses infection (as denoted in legend). Mean
and standard error of duplicate assays are shown. All influenza A virus infected mouse macrophages secrete significantly higher concentration of
TNF-a than mock infected cells (p,0.05).
doi:10.1371/journal.pone.0051057.g006
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infected BMDMW. WSN/33 also induced higher levels of TNF-
a than induced by influenza H5N1 (483/97) virus and human
influenza H1N1 (54/98) virus infected BMDMW although the
statistical significance was not achieved (Figure 6A). On the other
hand, in parallel with the gene expression profile, influenza H5N1
virus elicited more IP-10 (CXCL-10) secretion in BMDMW than
mock (p = 0.001), influenza H1N1 (54/98) (p = 0.05) and WSN/33
virus infected cells (p = 0.05) after 24 hours post-infection. IFN-
b was only detected (concentration of 48 rg/ml) in the supernatant
of influenza H5N1 virus (483/97) infected BMDMW at 24 hours
post-infection but we failed to detect any IFN-b secreted from the
supernatants of BMDMW after other influenza viruses infection at
various time post-infection. It should be noted that the limit of
detection of the mouse IFN-b ELISA was high (15.6 pg/ml) and
this lack of sensitivity of the assay is likely to be responsible for this
lack of detection of this cytokine in H1N1 virus infected cells.
Discussion
The mouse is not a natural host for influenza A virus and not all
strains of influenza A virus can infect and replicate productively in
mice in vivo or in mouse macrophages in vitro. Therefore mouse
macrophages may have some limitations as an experimental model
for the study of the pathogenesis of influenza virus. Nevertheless,
mouse model continues to be widely used because of its
convenience and more importantly, because of the wealth of
immunological reagents that are available. In addition, a full-range
of gene knockout mice is available and most of them are generated
in C57bl/6N mouse background, including TLR-3, TLR-4, TLR-
7, TLR-8 and MYD88 knockouts. The availability of TLR family
knockouts are important, as TLRs function as sensors to recognize
a large variety of infectious agents and elicit subsequent innate
immune response to limit further invasion [25]. Thus, the findings
in regard to influenza virus susceptibility, replication kinetics and
host responses in C57bl/6N derived primary cell-types is of
interest and can be useful to enhance our understanding of the
pathogenesis of influenza.
It remains controversial on whether influenza A viruses can
replicate in mouse macrophages in vitro. Different researchers have
reported a fully productive replication [27], a low level release of
infectious progeny [28], and abortive replication [29] or an
interruption of viral replication at the viral protein translation
stage [30]. These discrepancies may relate to the differences in
viral strains, culture methods, while the differences in susceptibility
of mouse macrophages to influenza virus was suggested to be
determined by genetic factors [26] and other parameters.
In our study, the influenza H5N1 virus infection of mouse bone
marrow derived macrophages led to the initiation of viral gene
transcription and viral protein synthesis. There was no release of
progeny virus and H5N1 virus infections of mouse bone barrow
derived macrophages appeared to be abortive (Figure 4B). The
influenza matrix gene copy number was found to increase with
time from 3 hours to 24 hours post-infection. The influenza viral
matrix and nucleoprotein were expressed in .90% of infected
mouse macrophages with both influenza H5N1 and H1N1 viruses
(Fig. 2). These findings suggested that double-stranded RNAs were
generated in influenza H5N1 virus-infected mouse macrophages.
Double-stranded RNA is a potent inducer of proinflammatory
cytokines, for instance, TNF-a and IFN-ß, which can trigger cell
signaling pathways such as those mediated through RNA-
dependent protein kinases and IFN regulatory factor 3 (IRF-3)
[31]. Therefore, the accumulation of the double-stranded RNA
within the H5N1 infected cell would partly explained the
induction of proinflammatory cytokines and chemokine, even in
the absence of productive virus replication. Therefore mouse
macrophages may still be a useful model for the detailed study of
the mechanisms of the H5N1 associated host responses and in
particular, to investigate the effect of specific gene knock-outs on
cell signaling.
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